Bioelectronica Announces Hypercell™ Expansion For Antibody Discovery, Closing Of Oversubscribed Series A Financing, Powering Local Hiring Growth And Expansion Of Facilities In Reno
Bioelectronica Announces Hypercell™ Expansion For Antibody Discovery, Closing Of Oversubscribed Series A Financing, Powering Local Hiring Growth And Expansion Of Facilities In Reno
07/19/21, 1:04 AM
Location
renoRound Type
series a
Bioelectronica® Corporation ("Bioelectronica") announced today that it has secured an undisclosed amount in its Series A financing round due to increased interest in HypercellTM, a new hardware tool that can be used to discover new antibodies using computer vision, which are industrially and technologically timely and relevant. This is proven by Hypercell's recent win of an industry award at ISAC, a leader in flow cytometry. The judges and audience unanimously agreed that Bioelectronica's approach was the most innovative compared to its' peers.
Company Info
Location
reno, nevada, united states
Additional Info
Bioelectronica® is a research-stage biotechnology company building intelligent, digital tools for biopharama discovery, cell screening and cell sorting. Bioelectronica's platform technology combines computer vision, biochemical reagents and consumer electronics to enable unique software-controlled workflows. We believe that by transforming biochemistry through digital innovation, we fundamentally change the speed and price of therapeutics discovery and development. For more information on how your workflow can benefit from Bioelectronica's step change innovation, contact Jonathan Hull or the team at hello@bioelectronica.com. Bioelectronica® and Hypercell® are registered trademarks of Bioelectronica. Hypercell® is For Research Use Only.
Follow Bioelectronica at www.bioelectronica.com, on LinkedIn at www.linkedin.com/company/bioelectronica, and on Twitter @singlecellsort.